As generics market stalls, Novartis said to weigh sale of copycat skin medications
admin 1st November 2017 Uncategorised 0Pick up one, cast off another. Just as Novartis agreed to buy a radiotherapy company, it’s reportedly considering a selloff of its generic dermatology products, a once-hot field that’s been hit by pressure on copycat drug prices. And some big-name bidders could come to the table.
More: As generics market stalls, Novartis said to weigh sale of copycat skin medications
Source: fierce